Transcend Therapeutics, founded in 2021, is a clinical-stage, neuroscience-focused company. It is dedicated to developing rapid-acting treatments for neuropsychiatric diseases.
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Transcend Therapeutics →Already a subscriber? Sign in
Xcout Intel tracks Transcend Therapeutics continuously — this profile deepens as new filings, funding, people and hiring data arrive.